Acyl-CoA binding protein (ACBP) is highly expressed in the developing human kidney.

Area of Science:

• Developmental Biology
• Molecular Biology
• Nephrology

Background:

• Acyl-CoA-binding protein (ACBP), also known as diazepam binding inhibitor (DBI), is a conserved multifunctional protein.
• ACBP exhibits intracellular and extracellular roles, including appetite stimulation and anabolic functions.
• Previous studies indicated high ACBP levels in erythrocytes, liver, kidney, and gut cells.

Purpose of the Study:

• To investigate the expression of ACBP in developing human fetal kidney tissues using immunohistochemistry.
• To determine the localization and potential role of ACBP during human nephrogenesis.

Main Methods:

• Immunohistochemistry was performed on 30 human fetal kidneys (13-19 weeks gestational age).
• Kidney samples were formalin-fixed, processed, and paraffin-embedded.
• Sections were stained with Hematoxylin and Eosin and PAS for morphological examination.

Main Results:

• ACBP was detected in all 30 fetal kidneys analyzed.
• ACBP expression was consistent across different gestational ages.
• Immunostaining revealed ACBP localization in the renal pelvis epithelium, papillae, collecting tubules, and proximal and distal tubules, but not in medullary regions or metanephric mesenchymal stem/progenitor cells.

Conclusions:

• ACBP is identified as a novel factor in human nephrogenesis.
• ACBP's localization suggests a role in inducing metanephric mesenchymal cell differentiation into glomerular structures.
• The protein's presence in tubules indicates a role in overall nephron development.